Prevention and management of herpes zoster in patients with rheumatoid arthritis and psoriatic arthritis: a clinical review
Affiliations
Affiliations
- Department of Public Health and Preventative Medicine, Oregon Health and Science University, Portland, OR, USA. winthrop@ohsu.edu.
- The First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Kitakyushu, Japan.
- Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Rheumatologie Hamburg, Struenseehaus, Hamburg, Germany.
- Rheumatology Department, Al Jahra Hospital, Al Jahra, Abu Halifa, Kuwait.
- Department of Medicine, Universidade Federal do Paraná, Curitiba, Brazil.
- Department of Medicine, The University of Alabama at Birmingham, Birmingham, AL, USA.
Abstract
The risk of herpes zoster (HZ) and HZ-related complications is increased in patients with rheumatoid arthritis (RA) and psoriatic arthritis (PsA) relative to the general population; therefore, HZ vaccination is recommended in these patient groups. In this literature-based review, we summarise the available evidence on the use of HZ vaccines in patients with RA and PsA, and discuss strategies for managing breakthrough infection. Currently available data show suboptimal rates of HZ vaccination among these patients and highlight a need for strategies to improve HZ vaccination programmes in clinical practice. Further clinical studies are also required to optimise the use of HZ vaccines in patients with RA and PsA, particularly with regard to determining the impact of different immunosuppressive therapy regimens on vaccine immunogenicity and, ultimately, efficacy, as well as the impact of vaccination on disease activity and safety.
Similar articles
Baumrin E, Van Voorhees A, Garg A, Feldman SR, Merola JF.J Am Acad Dermatol. 2019 Jul;81(1):102-110. doi: 10.1016/j.jaad.2019.03.017. Epub 2019 Mar 15.PMID: 30885757
Sheth H, Moreland L, Peterson H, Aggarwal R.J Rheumatol. 2017 Jan;44(1):11-17. doi: 10.3899/jrheum.160179. Epub 2016 Nov 15.PMID: 28042124
Koh JH, Lee J, Kim SH, Kwok SK, Ju JH, Park SH.J Rheumatol. 2018 Apr;45(4):465-469. doi: 10.3899/jrheum.170936. Epub 2018 Feb 1.PMID: 29419465
Galloway J, Raine T, Rivett L, Roberts J, Dews SA, Choy EH.Clin Exp Rheumatol. 2022 Jul;40(7):1432-1441. doi: 10.55563/clinexprheumatol/0jdyse. Epub 2021 Dec 7.PMID: 34874825 Review.
Meroni PL, Zavaglia D, Girmenia C.Clin Exp Rheumatol. 2018 Mar-Apr;36(2):317-328. Epub 2017 Dec 15.PMID: 29303710 Review.
Cited by
Venerito V, Stefanizzi P, Cantarini L, Lavista M, Galeone MG, Di Lorenzo A, Iannone F, Tafuri S, Lopalco G.Int J Mol Sci. 2023 Apr 9;24(8):6967. doi: 10.3390/ijms24086967.PMID: 37108130 Free PMC article.
Herpes Zoster Risk in Patients with Rheumatoid Arthritis and Its Association with Medications Used.
Dlamini ST, Htet KM, Theint ECC, Mayadilanuari AM, Li WM, Tung YC, Tu HP.Int J Environ Res Public Health. 2023 Jan 24;20(3):2123. doi: 10.3390/ijerph20032123.PMID: 36767490 Free PMC article.
Nakamura H, Nagasawa Y, Kobayashi H, Tsukamoto M, Takayama T, Kitamura N.Intern Med. 2022 Jul 1;61(13):2073-2076. doi: 10.2169/internalmedicine.9433-22. Epub 2022 Apr 23.PMID: 35466171 Free PMC article.
References
https://pubmed.ncbi.nlm.nih.gov/